Geode Capital Management, LLC I Teos Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 640,350 shares of ITOS stock, worth $5.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
640,350
Previous 620,258 3.24%
Holding current value
$5.27 Million
Previous $9.2 Million 28.98%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$10.09 - $17.97 $202,728 - $361,053
20,092 Added 3.24%
640,350 $6.54 Million
Q2 2024

Aug 09, 2024
BUY
$10.33 - $18.09 $379,503 - $664,590
36,738 Added 6.3%
620,258 $9.2 Million
Q1 2024

May 13, 2024
BUY
$9.89 - $13.64 $144,987 - $199,962
14,660 Added 2.58%
583,520 $7.96 Million
Q4 2023

Feb 13, 2024
BUY
$8.57 - $11.06 $315,144 - $406,709
36,773 Added 6.91%
568,860 $6.23 Million
Q3 2023

Nov 13, 2023
BUY
$10.95 - $14.6 $329,321 - $439,095
30,075 Added 5.99%
532,087 $5.83 Million
Q2 2023

Aug 11, 2023
BUY
$12.93 - $18.05 $268,594 - $374,952
20,773 Added 4.32%
502,012 $6.65 Million
Q1 2023

May 15, 2023
BUY
$13.02 - $22.62 $126,697 - $220,115
9,731 Added 2.06%
481,239 $6.55 Million
Q4 2022

Feb 13, 2023
BUY
$17.77 - $21.6 $437,621 - $531,943
24,627 Added 5.51%
471,508 $9.21 Million
Q3 2022

Nov 14, 2022
BUY
$18.6 - $27.25 $907,791 - $1.33 Million
48,806 Added 12.26%
446,881 $8.51 Million
Q2 2022

Aug 12, 2022
SELL
$16.57 - $35.1 $22,783 - $48,262
-1,375 Reduced 0.34%
398,075 $8.2 Million
Q1 2022

May 13, 2022
BUY
$31.92 - $47.45 $819,131 - $1.22 Million
25,662 Added 6.87%
399,450 $12.9 Million
Q4 2021

Feb 11, 2022
BUY
$26.23 - $47.86 $693,127 - $1.26 Million
26,425 Added 7.61%
373,788 $17.4 Million
Q3 2021

Nov 12, 2021
BUY
$23.91 - $29.58 $1.52 Million - $1.87 Million
63,385 Added 22.32%
347,363 $9.38 Million
Q2 2021

Aug 13, 2021
BUY
$17.9 - $36.1 $153,385 - $309,340
8,569 Added 3.11%
283,978 $7.28 Million
Q1 2021

May 12, 2021
BUY
$30.86 - $44.2 $2.91 Million - $4.17 Million
94,297 Added 52.07%
275,409 $9.41 Million
Q4 2020

Feb 12, 2021
BUY
$21.59 - $33.95 $665,317 - $1.05 Million
30,816 Added 20.5%
181,112 $6.13 Million
Q3 2020

Nov 13, 2020
BUY
$17.57 - $32.92 $2.64 Million - $4.95 Million
150,296 New
150,296 $3.71 Million

Others Institutions Holding ITOS

# of Institutions
165
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $293M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email